This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Husgafvel-Pursiainen, K. Articles by Benhamou, S. Search for Related Content PubMed PubMed Citation Articles by Husgafvel-Pursiainen, K. Articles by Benhamou, S.

p53 Mutations and Exposure to Environmental Tobacco Smoke in a Multicenter Study on Lung Cancer¹

Laboratory of Molecular and Cellular Toxicology, Finnish Institute of Occupational Health, FIN-00250 Helsinki, Finland, [K. H-P., A. K.]; IARC, 69372 Lyon Cedex 08, France [P. B., F. N.]; Institute of Environmental Medicine, Karolinska Institute, S-17177 Stockholm, Sweden [F. N., G. P.]; Institute of Carcinogenesis, 115478 Moscow, Russia [A. M.]; Institute of Public Health, 76256 Bucharest, Romania [V. C.]; Regional Epidemiological Centre, I-00198 Rome, Italy [C. F.]; and National Institute of Health and Medical Research (U521), 94805 Villejuif Cedex, France [S. B.]

Biomarker data may provide a way to strengthen the link between environmental tobacco smoke (ETS) exposure and lung cancer shown in epidemiological studies. We conducted a multicenter case-control study to investigate the association between ETS exposure and lung cancer in never-smokers using p53 mutations as a biomarker of tobacco-related carcinogenesis. Paraffin-embedded tissue or fresh tissue samples from 91 never-smokers and 66 smokers with histologically confirmed lung cancer and interview data about smoking habits and ETS exposure were analyzed for mutations in the p53 gene. Statistical analysis was performed using multivariate logistic regression. Among the lifelong nonsmokers, the overall mutation prevalence was 10% (nine cases). Among 48 never-smokers ever exposed to spousal ETS, 13% (six cases) showed mutations. Smokers exhibited 17 (26%) mutations. A 3-fold [odds ratio, 2.9; 95% confidence interval (CI), 1.2–7.2] increased risk of p53 mutation was observed for smokers as compared with all never-smokers combined (i.e., irrespective of ETS exposure). The increase was 4.4-fold (95% CI, 1.2–16.2) when compared with never-smokers without ETS exposure. Among never-smokers, the risk of mutation was doubled (odds ratio, 2.0; 95% CI, 0.5–8.7) for exposure to spousal ETS only, based on 6 exposed cases with mutation and 42 exposed cases without mutation. The risk was 1.5 (95% CI, 0.2–8.8) for those ever exposed to spousal or workplace ETS as compared with those never exposed to spousal or workplace ETS. For smokers, the most common mutation type was G:C to T:A transversion (31%), whereas G:C to A:T transitions were predominant among never smokers (57%). In conclusion, our study indicates a significant 3–4-fold increased risk of p53mutation in smoking lung cancer cases, and it suggests that mechanisms of lung carcinogenesis in ETS-exposed never-smokers include mutations in the p53 gene, similar to that seen in smokers. However, the mutation patterns observed also suggest a difference between smokers and never-smokers. Clearly, additional investigations of the role of p53 mutation as a biomarker for tobacco-related carcinogenesis, including that related to ETS, are indicated.

This article has been cited by other articles:

				W. Zhou, R. S. Heist, G. Liu, K. Asomaning, D. P. Miller, D. S. Neuberg, J. C. Wain, T. J. Lynch, and D. C. Christiani Second Hand Smoke Exposure and Survival in Early-Stage Non-Small-Cell Lung Cancer Patients Clin. Cancer Res., December 1, 2006; 12(23): 7187 - 7193. [Abstract] [Full Text] [PDF]

				F. Le Calvez, A. Mukeria, J. D. Hunt, O. Kelm, R. J. Hung, P. Taniere, P. Brennan, P. Boffetta, D. G. Zaridze, and P. Hainaut TP53 and KRAS Mutation Load and Types in Lung Cancers in Relation to Tobacco Smoke: Distinct Patterns in Never, Former, and Current Smokers Cancer Res., June 15, 2005; 65(12): 5076 - 5083. [Abstract] [Full Text] [PDF]

				G. Li, E. M. Sturgis, L.-E. Wang, R. M. Chamberlain, C. I. Amos, M. R. Spitz, A. K. El-Naggar, W. K. Hong, and Q. Wei Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck Carcinogenesis, October 1, 2004; 25(10): 1911 - 1916. [Abstract] [Full Text] [PDF]

				L. A. Snyder, E. R. Bertone, R. M. Jakowski, M. S. Dooner, J. Jennings-Ritchie, and A. S. Moore p53 Expression and Environmental Tobacco Smoke Exposure in Feline Oral Squamous Cell Carcinoma Vet. Pathol., May 1, 2004; 41(3): 209 - 214. [Abstract] [Full Text] [PDF]

				W.-M. Gao, M. Romkes, R. D. Day, J. M. Siegfried, J. D. Luketich, H. H. Mady, M. F. Melhem, and P. Keohavong Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer Carcinogenesis, October 1, 2003; 24(10): 1671 - 1676. [Abstract] [Full Text] [PDF]

				K. Leffondre, M. Abrahamowicz, J. Siemiatycki, and B. Rachet Modeling Smoking History: A Comparison of Different Approaches Am. J. Epidemiol., November 1, 2002; 156(9): 813 - 823. [Abstract] [Full Text] [PDF]

				K Husgafvel-Pursiainen Molecular biomarkers in studies on environmental cancer J. Epidemiol. Community Health, October 1, 2002; 56(10): 730 - 731. [Full Text] [PDF]

				M. Miyaki, T. Iijima, R. Ishii, Y. Kita, M. Koike, T. Kuroki, and T. Mori Increased Frequency of p53 Mutation in Sporadic Colorectal Cancer from Cigarette Smokers Jpn. J. Clin. Oncol., June 1, 2002; 32(6): 196 - 201. [Abstract] [Full Text] [PDF]

				D. M. DeMarini, S. Landi, D. Tian, N. M. Hanley, X. Li, F. Hu, B. C. Roop, M. J. Mass, P. Keohavong, W. Gao, et al. Lung Tumor KRAS and TP53 Mutations in Nonsmokers Reflect Exposure to PAH-Rich Coal Combustion Emissions Cancer Res., September 1, 2001; 61(18): 6679 - 6681. [Abstract] [Full Text] [PDF]

				K. H. Vahakangas, W. P. Bennett, K. Castren, J. A. Welsh, M. A. Khan, B. Blomeke, M. C. R. Alavanja, and C. C. Harris p53 and K-ras Mutations in Lung Cancers from Former and Never-Smoking Women Cancer Res., June 1, 2001; 61(11): 4350 - 4356. [Abstract] [Full Text] [PDF]

				K. E. Anderson, S. G. Carmella, M. Ye, R. L. Bliss, C. Le, L. Murphy, and S. S. Hecht Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Women Exposed to Environmental Tobacco Smoke J Natl Cancer Inst, March 7, 2001; 93(5): 378 - 381. [Abstract] [Full Text] [PDF]

				P. Hainaut and G. P. Pfeifer Patterns of p53 G{->}T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke Carcinogenesis, March 1, 2001; 22(3): 367 - 374. [Abstract] [Full Text] [PDF]